Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?
作者信息
Becker Richard C, Ortel Thomas L
机构信息
University of Cincinnati Heart, Lung, and Vascular Institute, Cincinnati, Ohio.
Departments of Medicine and Pathology, Division of Hematology, Duke University Medical Center, Durham, North Carolina.
出版信息
JAMA Intern Med. 2023 Jun 1;183(6):532-533. doi: 10.1001/jamainternmed.2023.0625.
Abstract
摘要
相似文献
1
Anticoagulation in Patients With COVID-19 Pneumonia-What Is the Optimal Intensity?新冠肺炎患者的抗凝治疗——最佳强度是多少？
JAMA Intern Med. 2023 Jun 1;183(6):532-533. doi: 10.1001/jamainternmed.2023.0625.
2
High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia.重症新型冠状病毒肺炎的大剂量预防性抗凝治疗
Chest. 2021 Jul;160(1):e94-e95. doi: 10.1016/j.chest.2021.02.036.
3
Therapeutic anticoagulation in COVID-19 patients.COVID-19患者的治疗性抗凝
Thromb Res. 2021 Dec;208:213. doi: 10.1016/j.thromres.2021.02.006. Epub 2021 Feb 16.
4
The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19.不同预防性抗凝剂量对新型冠状病毒肺炎患者预后的影响。
Thromb Res. 2021 Jun;202:14-16. doi: 10.1016/j.thromres.2021.02.031. Epub 2021 Mar 6.
5
Therapeutic anticoagulation in COVID-19 patients.COVID-19患者的治疗性抗凝
Thromb Res. 2021 Jul;203:72-73. doi: 10.1016/j.thromres.2021.04.027. Epub 2021 May 3.
6
When to use anticoagulation in COVID-19.新冠肺炎患者何时使用抗凝治疗。
Thromb Res. 2021 Aug;204:136-137. doi: 10.1016/j.thromres.2021.06.005. Epub 2021 Jun 16.
7
Managing Anticoagulation for COVID-19-Related Lung Transplantation.新冠病毒相关肺移植的抗凝管理
J Cardiothorac Vasc Anesth. 2023 Feb;37(2):334-335. doi: 10.1053/j.jvca.2022.10.022. Epub 2022 Oct 29.
8
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
9
Anticoagulation in COVID-19: DDI Perspective.COVID-19中的抗凝治疗：药物相互作用视角
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620959457. doi: 10.1177/1076029620959457.
10
When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities.长期护理机构中何时选择对SARS-CoV-2感染进行预防性抗凝治疗。
Aging Clin Exp Res. 2022 Dec;34(12):3171-3177. doi: 10.1007/s40520-022-02304-8. Epub 2022 Nov 25.
引用本文的文献
1
Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review.新型冠状病毒肺炎感染后的血管改变：一项综合文献综述
Life (Basel). 2024 Apr 24;14(5):545. doi: 10.3390/life14050545.
2
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials.低分子量肝素预防重症非危重型 COVID-19 患者临床恶化的效果：两项随机对照试验的联合分析。
Intern Emerg Med. 2024 Jan;19(1):71-79. doi: 10.1007/s11739-023-03439-w. Epub 2023 Oct 4.
Zotero 插件